Nutrition Scientists Float “Least-Harm Strategy” To Allow Health Claims
This article was originally published in The Tan Sheet
Executive Summary
Presenters at the IFT Wellness conference recommend that nutrition science move beyond randomized controlled trials – which typically are ill-suited to assess nutrient benefits – so development of new food and supplement products is not impeded.
You may also be interested in...
IOM Proposal Could Open Door For Biomarkers In Supplement Research
An Institute of Medicine report recommending a framework for assessing biomarkers for food and supplement health claims could help the supplement industry because it "will set the stage for being able to validate more biomarkers," said Andrew Shao, senior VP of scientific and regulatory affairs with the Council for Responsible Nutrition
FDA Adds Vitamin D To Osteoporosis Risk Reduction Health Claim
Bone-health claims may be made for vitamin D when the nutrient is combined with calcium, according to an FDA final rule
NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building
NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.